Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06326983
Other study ID # IRB-P00047028
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 9, 2024
Est. completion date April 1, 2026

Study information

Verified date May 2024
Source Boston Children's Hospital
Contact Jocelyn Booth, BSN
Phone 857-218-4585
Email jocelyn.booth@childrens.harvard.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective, randomized, controlled, non-inferiority study of patients undergoing tonsil surgeries at Boston Children's Hospital Waltham. The overall aim is to evaluate the efficacy of an opioid anesthetic plan (morphine, ketorolac, and acetaminophen versus an opioid sparing anesthetic plan (dexmedetomidine, ketorolac and acetaminophen) for perioperative analgesia and recovery time in patients undergoing tonsillectomies and tonsillotomies at Boston Children's Hospital Waltham. Secondary measures include rescue opioids administered in post-anesthesia care unit (PACU), re-operation secondary to bleeding, emergence delirium, post-operative nausea and vomiting, intraoperative hemodynamics, intraoperative vasopressor administration, and length of procedure.


Recruitment information / eligibility

Status Recruiting
Enrollment 58
Est. completion date April 1, 2026
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 3 Years to 17 Years
Eligibility Inclusion Criteria: - American Society of Anesthesia classification status I-III - Ages 3 years to 17 years - Scheduled for tonsillectomy or tonsillotomy with or without adenoidectomy at Boston Children's Hospital Waltham Exclusion Criteria: - Patients not scheduled for primary tonsillectomy/tonsillotomy. - Patients with known coagulopathies - Patients with previous chronic pain syndromes - Patients with any condition/indication that would prevent them from being able to be randomized (i.e. allergy to one of the study medications)

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dexmedetomidine
Dexmedetomidine (1mcg/kg bolus given intravenously at induction of anesthesia
Acetaminophen
Acetaminophen (12.5mg/kg with a maximum dose of 1 gram given intravenously at induction of anesthesia).
Ketorolac
Ketorolac 0.5mg/kg with a max dose of 30mg intravenously at the end of surgery.
Morphine
Morphine (0.1mg/kg given intravenously at induction of anesthesia)

Locations

Country Name City State
United States Boston Children's Hospital Waltham Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Boston Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Median Pain Scores in the Post-Anesthesia Care Unit Median Pain Scores in the Post-Anesthesia Care Unit measured by the numeric rating scale (NRS), Wong-Baker Faces scale or FLACC (Face, Legs, Activity, Cry, Consolability) scale as indicated based on patient age and development. All scales are done on a 0-10 point scale with 0 being no pain and 10 being the highest pain. entry to post-anesthesia care unit to 2-6 hours post-operatively
Primary Post-operative pain at 12-24 hours Pain categorized as none, mild, moderate, and severe. Taken from the routine follow-up nursing phone call. 12-24 hours post-operatively
Primary Post Operative Anesthesia Unit Length of Stay (hours) Length of time spent in the Post Operative Anesthesia Unit after tonsil surgery From entry to the Post Anesthesia Care Unit to exit from the Post-Anesthesia Care Unit. Assessed for up to 8 hours on the date of surgery
Secondary Opioid rescue medication administration Opioid rescue medications administered (reported as oral morphine equivalents) surgery end to 2-6 hours post-operatively
Secondary Emergence Delirium Incidence of emergence delirium defined as a score = 10 on the Pediatric Anesthesia Emergence Delirium Scale. Scores range 0-20 with 0 being no agitation/delirium to 20 being the highest level. surgery end to 2-6 hours post-operatively
Secondary Post-operative nausea and vomiting Incidence of episodes of emesis or administration of anti-emetics in the post-anesthesia care unit surgery end to 2-6 hours post-operatively
Secondary Procedure length (minutes) from incision time to patient being wheeled out of the operating room 0-60 minutes
Secondary Intraoperative Blood pressure (mmHg) Range of systolic blood pressure within 10 minutes of anesthesia induction 10 minutes
Secondary Intraoperative Heart rate (beats per second) Range of heart rate within 10 minutes of anesthesia induction 10 minutes
Secondary Vasopressor administration Intraoperative administration of vasopressors 0-60 minutes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care